Brief: Sienna Biopharmaceuticals Files 510(K) Submission With FDA For SNA-001, Its Novel Silver Photoparticle Technology To Remove Light Hair
07/10/2019 13:40
Oct 7 (Reuters) - Sienna Biopharmaceuticals Inc SNNA.O :
* SIENNA BIOPHARMACEUTICALS FILES 510(K) SUBMISSION WITH FDA
FOR
SNA-001, ITS NOVEL SILVER PHOTOPARTICLE TECHNOLOGY TO REMOVE
LIGHT HAIR
* SIENNA BIOPHARMACEUTICALS INC - INTENDS TO CONTINUE TO
MANAGE
AND OPERATE ITS BUSINESS DURING ITS CHAPTER 11 PROCEEDINGS
Source text for Eikon: ID:nGNX9BZkvp
Further company coverage: SNNA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sienna Biopharmaceuticals
See all newsU.S. STOCKS ON THE MOVE-Adobe, Oracle, Snap, Phreesia, Sarepta, Aquestive Therapeutics, Patterson-UTI
U.S. STOCKS ON THE MOVE-Lululemon, GE, Starbucks, Delta Air Lines, Lumber Liquidators, Lovesac
Sienna Biopharma: Falls on Nasdaq delisting plans
Brief: Sienna Biopharma Says Bankruptcy Court Approved Sale Of Assets Related To SNA-001 For $1.7 Mln In Cash
Brief: Sienna Biopharmaceuticals Announces Court Approval Of Chapter 11 Bidding Procedures